OncoRes Medical

Brandon Capital's $60m taypayer-funded biotech bets

Brandon Capital has put roughly $60 million of National Reconstruction Fund money into ten biotech companies and warns R&D tax changes would hurt deep tech; portfolio company Myricx Bio went to Novartis.

Also australiatimes.com

OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™.

Perth-based OncoRes Medical has secured $27 million from Brandon Capital's BB6 Fund, Morgans, Radar Ventures and others to advance its Elora breast-surgery imaging device through an Australian clinical trial toward FDA approval.

Also oncoresmedical.com

Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close totalling over A$430 m

Brandon Capital has completed a A$439 million final close for its sixth life sciences fund, bringing the National Reconstruction Fund Corporation and WA Government in alongside backers such as HESTA, Hostplus, CSL and QIC.

Through a different lens: How Kath Giles and OncoRes Are Reinventing Breast Cancer Surgery

Profile of OncoRes Medical CEO Katharine Giles, tracing her path from surgeon to venture investor and her leadership of the Western Australian medtech firm developing a handheld device for precise breast cancer surgery.

WA medtech companies ready to pitch at premier industry event

Eleven WA health organisations, including grant-backed Metabolic Health Solutions, head to the AusMedtech 2024 conference with ministerial support to present devices and pursue new partners.

State Government Backs OncoRes Medical with Funding to Manufacture Digital Cancer ImagingDevice in WA

OncoRes Medical has received a $3 million WA government grant to manufacture its surgical cancer-imaging device locally, its latest funding after a 2022 Series A2 and earlier state and federal grants.

Also Brandon BioCatalyst portfolio·Startup News (WA)

Australian medical device company secures additional $12.5m to advance its breast cancer imaging system towards clinical trials

Perth medtech OncoRes Medical announced $12.5 million: a $9.5 million Series A2 co-led by Brandon Capital and Australian Unity, plus a $3 million government grant, and hired a new R&D vice president.

Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Startup News (WA)

The Super Seven: Meet Blackbird's Seven New Associates

Blackbird presents its seven new investment associates, profiling their varied backgrounds across elite sport, science, banking, consulting and startups, plus prior roles at firms including Sprint Ventures, NZ Growth Capital Partners and AustralianSuper.